Seven start-ups will pitch at the EIT Health Summit
The first of the three European Health Catapult (EHC) Semifinals took place in Delft, The Netherlands on 24-26 September 2019. The BioTech semifinal was organised by TU Delft and hosted by Biotech Campus Delft and DSM. A total of 13 exceptional biotech start-ups participated in a two-day intensive training aimed at strengthening their value proposition and improving their pitching skills.
On the third day, which was combined with the EIT Health Investor Forum, the EHC start-ups gave a pitch in front of an investor jury. In total, the BioTech Catapult Semifinalists asked for approximately €112 million for future investments. In the afternoon, the start-ups had an opportunity to network and establish further connections with investors and health industry representatives.
Bart Haex, Business Creation Manager EIT Health Belgium-Netherlands: “The EHC-competition is a unique chance for start-ups to introduce themselves for the European health & healtcare sectors and to meet with intersting research institutes, companies and investors.”
The EHC investor jury selected seven BioTech start-ups to go through to the finals of the European Health Catapult competition which will be held during the EIT Health Summit on 2-3 December 20189 in Paris, France. There they will be joined by MedTech and Digital Health start-ups and all the finalists will pitch their innovations to compete for recognition, the attention of investors and prizes worth a total of €210 000.